Portfolio company
Acesion Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops ion channel inhibitors to treat atrial fibrillation for patients with cardiac arrhythmia.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Acesion Pharma ApS
This biotech company develops small-molecule drugs to treat atrial fibrillation by inhibiting ion channels for patients with cardiac arrhythmia.
Arvada
This drug discovery and development company creates medicines for patients with abnormal heart rhythms.
Maxwellbiomedical
This company develops an electrical stimulation platform for patients with atrial fibrillation to restore heart rhythms and function without destroying tissue.
Allosteros Therapeutics, Inc
The company develops small-molecule inhibitors of the protein kinase CaMKII to treat cardiovascular conditions including atrial fibrillation, ventricular arrhythmia and heart failure.
InCarda Therapeutics
This biopharmaceutical company develops inhaled therapies to treat patients with acute cardiovascular conditions such as paroxysmal atrial fibrillation.
Argá Medtech
This company develops non-thermal cardiac ablation systems and proprietary catheters for healthcare providers to treat atrial fibrillation and other cardiac arrhythmias.
Affera
This medical technology company develops integrated cardiac mapping and ablation systems for electrophysiologists to treat patients suffering from heart rhythm disorders.
Corify Care
Corify Care develops a non-invasive cardiac mapping system for clinicians to diagnose and plan treatments for patients with heart arrhythmias.
